McDermott + Bull has successfully placed Kris Krustangel as Vice President of Sales at Vertos Medical. In this pivotal role, Kris will drive the expansion of Vertos’s sales efforts and accelerate the commercial reach of the mild procedure, aiming to make it accessible to all suitable patients in the United States.
With nearly 20 years of experience in sales, business development, and commercial strategy, specifically in the neuromodulation/pain segment, Kris is an accomplished commercial sales growth executive. His track record includes significant domestic and international leadership roles, consistently exceeding performance timelines and revenue growth targets. Kris is known for his dedication to building high-performing teams and fostering a world-class organizational culture, with a keen focus on identifying and capitalizing on opportunities to surpass objectives.
Vertos Medical is at the forefront of interventional pain management, dedicated to developing minimally invasive treatments for lumbar spinal stenosis (LSS). Its flagship technology, Mild®, represents a breakthrough in LSS treatment. This image-guided outpatient procedure addresses a major root cause of LSS through an incision smaller than a baby aspirin, without the need for implants, general anesthesia, or stitches.